SCM
FLGT icon

Sterling Capital Management’s Fulgent Genetics FLGT Stock Holding History

Sterling Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.06K Sell
393
-306
-44% -$5.19K ﹤0.01% 2340
2026
Q1 		$11.1K Sell
699
-493
-41% -$10.7K ﹤0.01% 2314
2025
Q4 		$31.3K Sell
1,192
-235
-16% -$6.1K ﹤0.01% 1998
2025
Q3 		$32.3K Buy
1,427
+875
+159% +$18K ﹤0.01% 1921
2025
Q2 		$11K Buy
552
+197
+55% +$3.84K ﹤0.01% 2070
2025
Q1 		$6K Sell
355
-296
-45% -$5.04K ﹤0.01% 2068
2024
Q4 		$12K Buy
651
+580
+817% +$11.3K ﹤0.01% 2084
2024
Q3 		$1.54K Buy
+71
New +$1.59K ﹤0.01% 2316

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sterling Capital Management's FLGT Position: Q2 2026 in Review

Sterling Capital Management reduced its Fulgent Genetics (FLGT) stake by 44% in Q2 2026, selling an estimated $5.19K and leaving 393 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Sterling Capital Management first reported a position in FLGT in Q3 2024 and has held it in 8 quarters since. The position peaked at $32.3K in Q3 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Sterling Capital Management held 393 shares of Fulgent Genetics worth $8.06K as of Q2 2026.
  • Sterling Capital Management sold 306 Fulgent Genetics shares in Q2 2026, an estimated $5.19K.
  • Fulgent Genetics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2340 holding.
  • Sterling Capital Management first reported a position in Fulgent Genetics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Fulgent Genetics position peaked at $32.3K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.